161 related articles for article (PubMed ID: 7945976)
21. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
Männistö PT; Tuomainen P; Tuominen RK
Br J Pharmacol; 1992 Mar; 105(3):569-74. PubMed ID: 1628144
[TBL] [Abstract][Full Text] [Related]
22. Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Lorenc-Koci E
Behav Brain Res; 2014 Mar; 261():79-88. PubMed ID: 24361083
[TBL] [Abstract][Full Text] [Related]
23. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
Kaakkola S; Wurtman RJ
J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.
Metz GA; Whishaw IQ
Neuroscience; 2002; 111(2):325-36. PubMed ID: 11983318
[TBL] [Abstract][Full Text] [Related]
25. Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation.
Carey RJ; Pinheiro-Carrera M; Tomaz C; Huston JP
Brain Res; 1994 Sep; 658(1-2):145-54. PubMed ID: 7834335
[TBL] [Abstract][Full Text] [Related]
26. Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats.
Männistö PT; Tuomainen P; Toivonen M; Törnwall M; Kaakkola S
J Neural Transm Park Dis Dement Sect; 1990; 2(1):31-43. PubMed ID: 2113389
[TBL] [Abstract][Full Text] [Related]
27. The effect of L-dopa and carbidopa on behavioural recovery produced by ventral mesencephalic grafts in rats.
Blunt SB; Jenner P; Marsden CD
Prog Brain Res; 1990; 82():493-8. PubMed ID: 2127116
[No Abstract] [Full Text] [Related]
28. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
Nowak P; Bortel A; Dabrowska J; Biedka I; Slomian G; Roczniak W; Kostrzewa RM; Brus R
Neurotox Res; 2008; 13(3-4):231-40. PubMed ID: 18522902
[TBL] [Abstract][Full Text] [Related]
29. Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
Carey RJ
Brain Res; 1991 Dec; 568(1-2):205-14. PubMed ID: 1814568
[TBL] [Abstract][Full Text] [Related]
30. Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours.
Lane EL; Cheetham SC; Jenner P
Eur J Neurosci; 2005 Jan; 21(1):179-86. PubMed ID: 15654855
[TBL] [Abstract][Full Text] [Related]
31. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
Thornburg JE; Moore KE
J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
[TBL] [Abstract][Full Text] [Related]
32. Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.
Marin C; Bonastre M; Mengod G; Cortés R; Giralt A; Obeso JA; Schapira AH
Neurobiol Dis; 2014 Apr; 64():36-47. PubMed ID: 24370700
[TBL] [Abstract][Full Text] [Related]
33. Computerized rotometer apparatus for recording circling behavior.
Etemadzadeh E; Koskinen L; Kaakkola S
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):399-407. PubMed ID: 2501597
[TBL] [Abstract][Full Text] [Related]
34. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Pinna A; Fenu S; Morelli M
Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
[TBL] [Abstract][Full Text] [Related]
35. Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease.
Lindén IB; Nissinen E; Etemadzadeh E; Kaakkola S; Männistö P; Pohto P
J Pharmacol Exp Ther; 1988 Oct; 247(1):289-93. PubMed ID: 3171977
[TBL] [Abstract][Full Text] [Related]
36. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa.
Blunt SB; Jenner P; Marsden CD
Brain Res; 1992 Jun; 582(2):299-311. PubMed ID: 1393551
[TBL] [Abstract][Full Text] [Related]
37. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
38. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
Mandel RJ
Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
[TBL] [Abstract][Full Text] [Related]
39. Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930.
Britton DR; Kebabian JW; Curzon P
Eur J Pharmacol; 1991 Jul; 200(1):89-93. PubMed ID: 1685124
[TBL] [Abstract][Full Text] [Related]
40. L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
Camp DM; Loeffler DA; LeWitt PA
J Neurochem; 2000 Mar; 74(3):1229-40. PubMed ID: 10693956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
